{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:58:39Z","timestamp":1770980319333,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p>During the past five years an increasing number of patients have been diagnosed with congenital myasthenic syndromes (CMS) and a number of novel syndromes have been recognized and investigated. This presentation focuses on the CMS caused by defects in choline acetyltransferase, novel fast\u2010channel syndromes that hinder isomerization of the acetylcholine receptor from the closed to the open state, the consequences of deleterious mutations in the intermediate filament linker plectin, altered neuromuscular transmission in a centronuclear myopathy, and two recently identified CMS caused by congenital defects in glycosylation.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2012.06803.x","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T03:28:36Z","timestamp":1356146916000},"page":"54-62","source":"Crossref","is-referenced-by-count":23,"title":["New horizons for congenital myasthenic syndromes"],"prefix":"10.1111","volume":"1275","author":[{"given":"Andrew G.","family":"Engel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin\u2010Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Selcen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Sine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.2017"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21560"},{"key":"e_1_2_11_4_2","first-page":"1306","article-title":"Surface\u2010entropy reduction used in the crystallization of human choline acetyltransferase","volume":"61","author":"Kim A.R.","year":"2005","journal-title":"Acta Crystallogr."},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi061536l"},{"key":"e_1_2_11_6_2","first-page":"449","article-title":"Highly fatal fast\u2010channel congenital syndrome caused by AChR \u025b subunit mutation at the agonist binding site","volume":"79","author":"Engel A.G.","year":"2011","journal-title":"Neurology"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(04)00115-1"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0020134"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2009.02.020"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2908"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63415"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(90)90275-Q"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.200509283"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199908000-00006"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820882bd"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cef7f9"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.02.012"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.03.002"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21126"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2010.03.011"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70040-6"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.01.008"},{"key":"e_1_2_11_23_2","article-title":"Congenital myasthenic syndrome, autophagic myopathy, and cognitive dysfunction caused by mutaions in DPAGT1","author":"Selcen D.","year":"2012","journal-title":"Ann. Neurol."},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.05.022"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2012.06803.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2012.06803.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:07:57Z","timestamp":1695013677000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2012.06803.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1749-6632.2012.06803.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06803.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}